Late onset hearing loss: A Significant complication of cancer survivors treated with cisplatin containing chemotherapy regimens

Journal of Pediatric Hematology/Oncology

Volumn 32, Issue 2, 2010, Pages 119-123

  Kolinsky, Daniel C ^a   Hayashi, Susan S ^b   Karzon, Roanne ^b   Mao, Jingnan ^a   Hayashi, Robert J ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ST LOUIS CHILDREN S HOSPITAL   (United States)

Author keywords

Audiology; Cancer survivor; Cisplatin; Ototoxicity

Indexed keywords

CARBOPLATIN; CISPLATIN;

ADOLESCENT; ARTICLE; AUDIOLOGY; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVOR; CHILD; CHILDHOOD CANCER; CONTROLLED STUDY; FEMALE; HEARING AID; HEARING LOSS; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MEDULLOBLASTOMA; NEUROBLASTOMA; OTOTOXICITY; PRIORITY JOURNAL; RISK FACTOR;

ADOLESCENT; ANTINEOPLASTIC AGENTS; CHILD; CHILD, PRESCHOOL; CISPLATIN; COCHLEA; FEMALE; HEARING LOSS; HUMANS; INFANT; MALE; NEOPLASMS; RETROSPECTIVE STUDIES; SURVIVORS;

EID: 77949449192     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/MPH.0b013e3181cb8593     Document Type: Article

References (18)

1. McKeage MJ. Comparative adverse effect profiles of platinum drugs. Drug Saf. 1995;13:228-244
2. Skinner R, Pearson AD, Amineddine HA, et al. Ototoxicity of cisplatinum in children and adolescents. Br J Cancer. 1990;61: 927-931
3. Brock PR, Bellman SC, Yeomans EC, et al. Cisplatin ototoxicity in children: a practical grading system. Med Pediatr Oncol. 1991;19:295-300
4. McHaney VA, Thibadoux G, Hayes FA, et al. Hearing loss in children receiving cisplatin chemotherapy. J Pediatr. 1983; 102:314-317
5. Pollera CF, Marolla P, Nardi M, et al. Very high-dose cisplatin-induced ototoxicity: a preliminary report on early and long-term effects. Cancer Chemother Pharmacol. 1988;21: 61-64
6. Schaefer SD, Post JD, Close LG, et al. Ototoxicity of low- and moderate-dose cisplatin. Cancer. 1985;56:1934-1939
7. Schell MJ, McHaney VA, Green AA, et al. Hearing loss in children and young adults receiving cisplatin with or without prior cranial irradiation. J Clin Oncol. 1989;7:754-760
8. Pasic TR, Dobie RA. Cis-platinum ototoxicity in children. Laryngoscope. 1991;101:985-991
9. Weatherly RA, Owens JJ, Catlin FI, et al. Cis-platinum ototoxicity in children. Laryngoscope. 1991;101:917-924
10. Gregg RB, Wiorek LS, Arvedson JC. Pediatric audiology: a review. Pediatr Rev. 2004;25:224-234
11. Davis JM, Elfenbein J, Schum R, et al. Effects of mild and moderate hearing impairments on language, educational, and psychosocial behavior of children. J Speech Hear Disord. 1986; 51:53-62
12. Bess FH, Dodd-Murphy J, Parker RA. Children with minimal sensorineural hearing loss: prevalence, educational performance, and functional status. Ear Hear. 1998;19:339-354
13. Bertolini P, Lassalle M, Mercier G, et al. Platinum compoundrelated ototoxicity in children: long-term follow-up reveals continuous worsening of hearing loss. J Pediatr Hematol Oncol. 2004;26:649-655
14. Knight KR, Kraemer DF, Neuwelt EA. Ototoxicity in children receiving platinum chemotherapy: underestimating a commonly occurring toxicity that may influence academic and social development. J Clin Oncol. 2005;23:8588-8596
15. Berg AL, Spitzer JB, Garvin JH Jr. Ototoxic impact of cisplatin in pediatric oncology patients. Laryngoscope. 1999;109:1806-1814
16. Diefendorf AO. The test battery approach in pediatric audiology. In: Bess FH, ed. Children With Hearing Impairment: Contemporary Trends. Nashville: Vanderbilt Bill Wilkerson Center Press; 1998:71-81
17. Laurell GF. Combined effects of noise and cisplatin: shortand long-term follow-up. Ann Otol Rhinol Laryngol. 1992;101: 969-976
18. Gratton MA, Salvi RJ, Kamen BA, et al. Interaction of cisplatin and noise on the peripheral auditory system. Hear Res. 1990;50:211-223